Laminopathies Becker muscular dystrophy Motoneuron Heart failure Neuromuscular junction Mechanotransduction Myopathies Rare neuromuscular diseases Glutamate Neuromuscular diseases LMNA gene Exercise COVID-19 CMS ALS Satellite cells Myotonic Dystrophy type 1 Actin Inflammation Transgenic mouse model Myositis Mice Heart Cell therapy Thymus CTG repeat contractions Lamin A/C Nuclear envelope PABPN1 Errance diagnostique Mouse model Cardiomyopathy Humans Lamin A/C LMNA gene Cytoskeleton AAV Autoantibodies Congenital myopathy Congenital muscular dystrophy Fabry disease Dynamin 2 Myasthenia Gravis MG Laminopathie Genotype phenotype correlation Aging MBNL Laminopathy Myogenesis Gene therapy Brain Autoimmunity DMD Spinal muscular atrophy Therapy Trinucleotide repeat expansion Rare diseases Calcium OPMD Satellite cell Treatment Male Myopathy Muscular dystrophy RNA biology Animals Myoblasts Aged Regeneration Myotonic Dystrophy Transcriptomics Biomarker Centronuclear myopathy Myasthenia gravis Neuromuscular disease RNA interference Alternative splicing Amyotrophic lateral sclerosis Cytokines Myotonic dystrophy type 1 Muscle regeneration Dermatomyositis Autophagy Muscle Astrocyte LMNA Genetics Fibrosis Biomarkers Dystrophin Thérapie génique Dilated cardiomyopathy CRISPRi Long read sequencing Antisense oligonucleotides Outcome measures FSHD Autoimmune diseases Myotonic dystrophy Skeletal muscle Duchenne muscular dystrophy